SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 106.00+0.8%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3006)12/10/2013 2:46:38 PM
From: scaram(o)uche  Read Replies (1) of 3202
 
>> Geron's results don't seem to beat that <<

Yes, they do. The pathology slides show fat and sassy marrow in some patients, normal marrow. Jakafi takes forever to stabilize fibrosis in a small percentage of patients.

That said, I don't expect jakafi to be a stand-alone therapy, and believe that the panobinostat combo is only a first shot.

Those who ignore V617F, just because jak inhibitors are not curative? Big mistake.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News